Amgen Inc. (AMGN) - 5i Research

Amgen Inc. (AMGN $292.62)
- $292.62 P/E (TTM): 27.03X Cap: $159.60B
- View AMGN Profile
- View Questions on AMGN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $292.62)
- $292.62 P/E (TTM): 27.03X Cap: $159.60B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $481.28)
- $481.28 P/E (TTM): 66.89X Cap: $172.16B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $206.57)
- $206.57 P/E (TTM): 88.33X Cap: $365.12B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $698.05)
- $698.05 P/E (TTM): 57.06X Cap: $663.68B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $381.61)
- $381.61 P/E (TTM): 50.58X Cap: $146B
- View SYK Profile
- View Questions on SYK
Novo Nordisk A/S (NVO $53.75)
- $53.75 P/E (TTM): 14.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: I sold a portion of my NVO holdings a while ago, and am not inclined to buy it back just now. What would you see as the best buy in the US healthcare sector these days; possibly as a compliment to NVO, but not necessarily?

Read Answer Asked by David on August 13, 2025

Amgen Inc. (AMGN $292.62)
- $292.62 P/E (TTM): 27.03X Cap: $159.60B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $481.28)
- $481.28 P/E (TTM): 66.89X Cap: $172.16B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $206.57)
- $206.57 P/E (TTM): 88.33X Cap: $365.12B
- View ABBV Profile
- View Questions on ABBV
Stryker Corporation (SYK $381.61)
- $381.61 P/E (TTM): 50.58X Cap: $146B
- View SYK Profile
- View Questions on SYK
UnitedHealth Group Incorporated (DE) (UNH $308.49)
- $308.49 P/E (TTM): 12.73X Cap: $275.33B
- View UNH Profile
- View Questions on UNH
iShares U.S. Medical Devices ETF (IHI $61.63)
- $61.63 P/E (TTM): 164.7X Cap: $4.32B
- View IHI Profile
- View Questions on IHI

Q: I have been reviewing my health care holdings and I am disappointed in the whole sector. Their percentage of my holdings has dropped, and if I rebalance I should be adding another 50% to these holdings. I am unhappy with IHI and UNH, even ISRG is in the doldrums. Your thoughts on adding to the health care sector and these companies/ETFs at this time. Are there other companies much better suited that I am missing. I am tempted to remove the whole sector from my portfolio, as I am comfortable with risk.

Read Answer Asked by Gordon on August 14, 2025

Amgen Inc. (AMGN $292.62)
- $292.62 P/E (TTM): 27.03X Cap: $159.60B
- View AMGN Profile
- View Questions on AMGN

Q: Amgen beat on earnings and revenues, quite handily, and yet the stock is down 5% today. Personally, I think Amgen is a best-in-class biotech and will continue to be a long-term holder, but I would like your take on the market reaction.

Read Answer Asked by David on August 11, 2025